Non-contrast DWI for Supplemental Screening

Active, not recruitingOBSERVATIONAL
Enrollment

269

Participants

Timeline

Start Date

July 16, 2018

Primary Completion Date

September 30, 2026

Study Completion Date

July 31, 2029

Conditions
Breast Cancer
Interventions
DEVICE

Non-contrast DWI

Diffusion-weighted imaging (DWI) is a non-contrast MRI technique that typically can be acquired in under 5 minutes. DWI reflects the microscopic cellular environment and can demonstrate differences between normal and malignant breast tissue without the aid of intravenous gadolinium.

DEVICE

Non-contrast MRI

Non-contrast MRI scans will include DWI along with anatomical T1-weighted and T2-weighted sequences.

Trial Locations (2)

97239

Oregon Health & Science University, Portland

98109

Seattle Cancer Care Alliance, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Washington

OTHER

NCT03607552 - Non-contrast DWI for Supplemental Screening | Biotech Hunter | Biotech Hunter